Lipoprotein(a): an important consideration for DAPT therapy after PCI

Cardiol J. 2024;31(2):365-366. doi: 10.5603/cj.98494.

Kongyong Cui^{1

2

3}, Kefei Dou^{4

5

6}

¹ Department of Cardiology, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² State Key Laboratory of Cardiovascular Disease, Beijing, China.
³ National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
⁴ Department of Cardiology, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. drdoukefei@126.com.
⁵ State Key Laboratory of Cardiovascular Disease, Beijing, China. drdoukefei@126.com.
⁶ National Clinical Research Center for Cardiovascular Diseases, Beijing, China. drdoukefei@126.com.

No abstract available

MeSH terms